Alpine Biomed Corp. (extinct)

Alpine Biomed Corp. (extinct)

Alpine Biomed Corp. (extinct)

Overview
Date Founded

1994

Headquarters

17800 Newhope Street,Suite B,Fountain Valley, CA 92708

Type of Company

Private

Industries

Medical Products & Equipment
Hospitals & Patient Services
Wholesale: Medical Supplies & Pharmaceuticals

Company Description

Alpine Biomed Corp. designs, manufactures, and distributes diagnostic equipment & accessories. Its products are used for gastroesophageal & acid reflux disease and neurological conditions, such as carpal tunnel syndrome and sleep disorders. The company was founded in 1994 by Clark Westcott and Khai Luong and is headquartered in Fountain Valley, CA

Paths to Alpine Biomed Corp.
Potential Connections via
Relationship Science
You
Alpine Biomed Corp.
Recent Transactions
Details Hidden

Natus Medical, Inc. purchases Alpine Biomed Corp.

Details Hidden

Alpine Biomed Corp., Alpine Biomed Holdings Corp. purchase Stellate Systems, Inc.

Details Hidden

Water Street Healthcare Partners LLC purchases Alpine Biomed Corp.

Transaction Advisors
Legal Advisor

Advised onNatus Medical, Inc. purchases Alpine Biomed Corp.

Investors
Details Hidden

Former Director & Vice President-Engineering at Alpine Biomed Corp.

Details Hidden

Water Street Healthcare Partners focuses exclusively on investments in the healthcare sector. The firm invests in middle-market companies and lower-priority divisions of global companies in the following areas: diagnostic devices, medical products, pharmaceutical services, specialty distribution, specialty pharmaceuticals and specialty services. Water Street does not invest in biotechnology, traditional healthcare facilities such as hospitals or nursing homes or in early-stage companies without positive cash flow. They firm looks for companies with: (1) a leading market share (2) established brands and/or strong customer relationships (3) strong sales and distribution capabilities (4) platforms with the potential for expansion into new products, services and technologies and (5) management teams interested in retaining an ownership stake. Investments typically range from $50 million to $500 million.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Alpine Biomed Corp.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Alpine Biomed Corp.'s profile does not indicate a business or promotional relationship of any kind between RelSci and Alpine Biomed Corp..